Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis

Anesthesia and Analgesia

Volumn 110, Issue 6, 2010, Pages 1630-1635

  Forget, Patrice ^a   Vandenhende, Julie ^a   Berliere, Martine ^b   MacHiels, Jean Pascal ^c   Nussbaum, Benoît ^a   Legrand, Catherine ^d   De Kock, Marc ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Departments of Gynecology   (Australia)

^c Departments of Oncology   (Australia)

^d Institute of Statistics   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DICLOFENAC; KETAMINE; KETOROLAC; PIRITRAMIDE; PROPOFOL; SUFENTANIL; THIOPENTAL;

ADULT; ANALGESIA; AXILLARY DISSECTION; BLOOD TRANSFUSION; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MASTECTOMY; OPERATION DURATION; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SURGICAL TECHNIQUE; WOUND INFECTION;

ADULT; AGED; ANALGESICS; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST NEOPLASMS; DATA COLLECTION; DISEASE-FREE SURVIVAL; ENDPOINT DETERMINATION; FEMALE; HUMANS; INTRAOPERATIVE CARE; KAPLAN-MEIERS ESTIMATE; KETOROLAC; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PAIN, POSTOPERATIVE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 77953218308     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181d2ad07     Document Type: Review

References (27)

1. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003;10:972-992
2. Wrona D. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J Neuroimmunol 2006;172:38-58
3. Page GG. Immunologic effects of opioids in the presence or absence of pain. J Pain Symptom Manage 2005;29:S25-31
4. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006;105: 660-664
5. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 2008;109:180-187
6. Rutgers EJ. Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol 2005;3:568-576
7. Birido N, Geraghty JG. Quality control in breast cancer surgery. Eur J Surg Oncol 2005;31:577-586
8. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thürlimann B, Senn HJ; Panel members. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005;16:1569-1583 (Pubitemid 41511089)
9. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ; 10th St. Gallen conference. Ann Oncol 2007;18: 1133-1144
10. Lee MC, Jasi R. Postmastectomy radiation therapy: indications and controversies. Surg Clin North Am 2007;87:511-526
11. Smith BD, Smith GL, Haffty BG. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol 2005;23:1409-1419
12. Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long term survivors of breast cancer. Breast Cancer Res Treat 2008; 107:309-330
13. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, Bessler H. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 1996;82:492-497
14. Aubrun F, Valade N, Coriat P, Riou B. Predictive factors of severe postoperative pain in the postanesthesia care unit. Anesth Analg 2008;106:1535-1541
15. Romero-Sandoval A, Eisenach JC. Clonidine reduces hypersensitivy and alters the balance pro-and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis. Brain Behav Immun 2007;21:569-580
16. De Kock M, Lavand'homme P, Waterloos H. 'Balanced analgesia' in the perioperative period: is there a place for ketamine? Pain 2001;92:373-380
17. Bentley MW, Stas JM, Johnson JM, Viet BC, Garett N. Effects of preincisional ketamine treatment in natural killer cell activity and postoperative pain management after oral maxillofacial surgery. AANA J 2005;73:427-436
18. Mazar J, Rogachev B, Shaked G, Ziv NY, Czeiger D, Chaimovitz C, Zlotnik M, Mukmenev I, Byk G, Douvdevani A. Involvement of adenosine in the antiiflammatory action of ketamine. Anesthesiology 2005;102:1174-1181
19. Waymack JP, Flescher E, Venkatraman J, Fernandes G, Guzman RF, Yurt RW, Mason AD Jr, Pruitt BA Jr. Effect of prostaglandin E in multiple experimental models. VIII. Effect on host response to metastatic tumor. J Surg Oncol 1991;48:239-245
20. Okuno K, Jinnai H, Lee YS, Nakamura K, Hirohata T, Shigeoka H, Yasutomi M. A high level of prostaglandin E2 (PGE2) in the portal vein suppresses liver-associated immunity and promotes liver metastases. Surg Today 1995;25:954-958
21. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2008;15:2042-2052
22. Melamed R, Rosenne E, Shakhar K, Schwartz Y, Abudarham N, Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 2005;19:114-126
23. Singh B, Lucci A. role of cyclooxygenase-2 in breast cancer. J Surg Res 2002;108:173-179
24. Yakar I, Melamed R, Shakhar G, Rosenne E, Abudarham N, page GG, Ben-Eliyahu S. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann Surg Oncol 2003;10:469-479
25. Stanojeviæ-Bakiæ N, Vuckoviæ-Dekiæ L, Radomiroviæ S, Juraniæ Z, Jovanoviæ N. The influence of surgery and anesthesia on lymphocyte functions in breast cancer patients: in vitro effects of indomethacin. Neoplasma 1999;46:54-60
26. Morré DJ, Morre DM. tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal antiinflammatory drugs (NSAIDS). Mol Cell Biochem 2006;283: 159-167
27. Mansell J, Monipenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM, Wilson CR, Angerson WJ, Doughty JC. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast cancer Res Treat 2009;117:91-98